Loading clinical trials...
Loading clinical trials...
The Efficacy and Safety of Liposomal Bupivacaine Plus Bupivacaine Transversus Abdominis Plane Block for Postoperative Pain in Patients Undergoing Laparoscopic Surgery in Gynecologic Oncology:A Multi-Center Randomized Controlled Trial
Conditions
Interventions
Bupivacaine hydrochloride
Liposomal bupivacaine plus bupivacaine
Locations
1
China
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China
Start Date
March 10, 2026
Primary Completion Date
March 30, 2027
Completion Date
June 30, 2027
Last Updated
March 17, 2026
NCT07432711
NCT07427043
NCT06305975
NCT06864702
NCT06556498
NCT05005117
Lead Sponsor
Beijing Tiantan Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions